EPHA2 and prostate carcinoma: In summary, both ephrinA1-Fc and 135H12 (at the highest concentration) can revert the pro-migration signaling associated with EphA2 expression in PC-3 prostate cancer cells, while cell proliferation was apparently not significantly affected by either treatment with 135H12 or by ephrinA1-Fc.